PCVX

PCVX

USD

Vaxcyte Inc. Common Stock

$34.460-0.670 (-1.907%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$35.130

Haut

$35.390

Bas

$34.260

Volume

1.06M

Fondamentaux de l'Entreprise

Capitalisation Boursière

4.4B

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

2.50M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $27.66Actuel $34.460Haut $121.055

Actualités Connexes

GlobeNewswire

Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update

-- Company Reported Positive Topline Safety, Tolerability and Immunogenicity Data from Phase 2 Dose-Finding Study of VAX-24 in Healthy Infants; Balance of Data Expected by End of 2025 -- -- Initiated Second and Final

Voir plus
Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors

SAN CARLOS, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (NASDAQ:PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today

Voir plus
Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors
Analyst Upgrades

Cantor Fitzgerald Initiates Coverage On Vaxcyte with Overweight Rating

Cantor Fitzgerald analyst Carter Gould initiates coverage on Vaxcyte with a Overweight rating.

Voir plus
Cantor Fitzgerald Initiates Coverage On Vaxcyte with Overweight Rating

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.